Evidence map›Paper›PMID 33868172›Full record

ArticleFrontiers in endocrinology2021

Obesity and Dietary Added Sugar Interact to Affect Postprandial GLP-1 and Its Relationship to Striatal Responses to Food Cues and Feeding Behavior.

Sabrina Jones, Shan Luo, Hilary M Dorton, Alexandra G Yunker, Brendan Angelo, Alexis Defendis, John R Monterosso, Kathleen A Page

Open access · goldAbstract read
In one paragraph

Article in Frontiers in endocrinology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.1field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 13 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Sabrina JonesDivision of Endocrinology, Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, United States.
Shan LuoDivision of Endocrinology, Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, United States.
Hilary M DortonKeck School of Medicine, Diabetes and Obesity Research Institute, University of Southern California, Los Angeles, CA, United States.
Alexandra G YunkerDivision of Endocrinology, Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, United States.
Brendan AngeloDivision of Endocrinology, Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, United States.
Alexis DefendisDivision of Endocrinology, Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, United States.
John R MonterossoDepartment of Psychology, University of Southern California, Los Angeles, CA, United States.
Kathleen A PageDivision of Endocrinology, Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, United States.
University of Southern California · US

Funding

Southern California Clinical and Translational Science InstituteUL1TR001855 · NCATS · UNIVERSITY OF SOUTHERN CALIFORNIA · PI Thomas A Buchanan, Michele D. Kipke · 2016 to 2026
$81.3M
Neural Mechanisms for Appetitive Responses to High Reward FoodsR01DK102794 · NIDDK · UNIVERSITY OF SOUTHERN CALIFORNIA · PI PAGE, KATHLEEN ALANNA · 2016 to 2020
$2.7M
NCATS NIH HHS UL1 TR001855NIDDK NIH HHS R01 DK102794
6 · The paper itself

Abstract

It has been hypothesized that the incretin hormone, glucagon-like peptide-1 (GLP-1), decreases overeating by influencing mesolimbic brain regions that process food-cues, including the dorsal striatum. We previously showed that habitual added sugar intake was associated with lower glucose-induced circulating GLP-1 and a greater striatal response to high calorie food cues in lean individuals. Less is known about how dietary added sugar and obesity may interact to affect postprandial GLP-1 and its relationship to striatal responses to food cues and feeding behavior. The current study aimed to expand upon previous research by assessing how circulating GLP-1 and striatal food cue reactivity are affected by acute glucose consumption in participants with varied BMIs and amounts of habitual consumption of added sugar. This analysis included 72 participants from the Brain Response to Sugar Study who completed two study visits where they consumed either plain water or 75g glucose dissolved in water (order randomized; both drinks were flavored with non-caloric cherry flavoring) and underwent repeated blood sampling, a functional magnetic resonance imaging (fMRI) based food-cue task, and an ad-libitum buffet meal. Correlations between circulating GLP-1 levels, striatal food-cue reactivity, and food intake were assessed, and interactions between obesity and added sugar on GLP-1 and striatal responses were examined. An interaction between BMI and dietary added sugar was associated with reduced post-glucose GLP-1 secretion. Participants who were obese and consumed high levels of added sugar had the smallest increase in plasma GLP-1 levels. Glucose-induced GLP-1 secretion was correlated with lower dorsal striatal reactivity to high-calorie versus low-calorie food-cues, driven by an increase in reactivity to low calorie food-cues. The increase in dorsal striatal reactivity to low calorie food-cues was negatively correlated with sugar consumed at the buffet. These findings suggest that an interaction between obesity and dietary added sugar intake is associated with additive reductions in postprandial GLP-1 secretion. Additionally, the results suggest that changes to dorsal striatal food cue reactivity through a combination of dietary added sugar and obesity may affect food consumption.

Indexed as

Energy IntakeFeeding BehaviorAdultAnimalsAppetiteBehavior, AnimalBlood GlucoseBody Mass IndexCorpus StriatumCuesFemaleGastric Inhibitory PolypeptideGlucagon-Like Peptide 1GlucoseHumansInsulinBlood GlucoseGastric Inhibitory PolypeptideGlucagon-Like Peptide 1GlucoseInsulinappetite and food intakedietary sugarfeeding behaviorfMRIglucagon-like peptide-1obesitystriatum

Identifiers

PMID33868172
PMCPMC8044510
OpenAlexW3147380971

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.